Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers

4 Apr 2013

Abstract excerpt

BACKGROUND AND AIMS: Transcription factors of the forkhead box P (FOXP1-4) family have been implicated in various human cancer types before. The relevance and role of neuronal transcription factor FOXP2 in prostate cancer is unknown. METHODS: A tissue microarray containing samples from more than 11 000 prostate cancers from radical prostatectomy specimens with clinical follow-up data was analysed for FOXP2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to FOXO transcription factor regulation
Share to Prostate Cancer Treatment and Research
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23559350
DOI: 10.1136/jclinpath-2012-201335

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancersPMID 23559350Read ↗

<i>FOXP2</i> confers oncogenic effects in prostate cancer through activating MET signallingSemantic proximity Read ↗

Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cellsSemantic proximity Read ↗

Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers.Semantic proximity Read ↗

Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate.Semantic proximity Read ↗

Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesisSemantic proximity Read ↗

High Expression of FOXP2 Is Associated with Worse Prognosis in Glioblastoma.Semantic proximity Read ↗

In Vivo Application of CRISPR/Cas9 Revealed Implication of Foxa1 and Foxp1 in Prostate Cancer Proliferation and Epithelial PlasticitySemantic proximity Read ↗

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG‐fusion positive and PTEN deleted prostate cancersSemantic proximity Read ↗

Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.Semantic proximity Read ↗

Integrative Analysis of FOXP1 Function Reveals a Tumor-Suppressive Effect in Prostate CancerSemantic proximity Read ↗

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersSemantic proximity Read ↗

FOXA2-Interacting FOXP2 Prevents Epithelial-Mesenchymal Transition of Breast Cancer Cells by Stimulating E-Cadherin and PHF2 TranscriptionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.